Impax Asset Management Group plc raised its holdings in TriMas Co. (NASDAQ:TRS – Free Report) by 216.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 410,000 shares of the industrial products company’s stock after acquiring an additional 280,431 shares during the quarter. Impax Asset Management Group plc’s holdings in TriMas were worth $10,467,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of the business. BNP Paribas Financial Markets lifted its stake in TriMas by 79.8% during the first quarter. BNP Paribas Financial Markets now owns 20,225 shares of the industrial products company’s stock valued at $541,000 after buying an additional 8,978 shares in the last quarter. Quantbot Technologies LP increased its holdings in shares of TriMas by 5.7% in the 1st quarter. Quantbot Technologies LP now owns 8,933 shares of the industrial products company’s stock valued at $239,000 after purchasing an additional 478 shares during the period. Vanguard Group Inc. increased its holdings in shares of TriMas by 2.3% in the 1st quarter. Vanguard Group Inc. now owns 4,358,524 shares of the industrial products company’s stock valued at $116,503,000 after purchasing an additional 100,068 shares during the period. Price T Rowe Associates Inc. MD increased its holdings in shares of TriMas by 6.6% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 23,870 shares of the industrial products company’s stock valued at $639,000 after purchasing an additional 1,478 shares during the period. Finally, Kennedy Capital Management LLC increased its holdings in shares of TriMas by 197.8% in the 1st quarter. Kennedy Capital Management LLC now owns 273,200 shares of the industrial products company’s stock valued at $7,303,000 after purchasing an additional 181,447 shares during the period. 99.42% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities analysts have recently weighed in on the company. BWS Financial reiterated a “buy” rating and issued a $40.00 target price on shares of TriMas in a report on Tuesday, November 5th. StockNews.com upgraded TriMas from a “sell” rating to a “hold” rating in a report on Wednesday.
TriMas Stock Down 0.2 %
Shares of TriMas stock opened at $25.54 on Friday. The stock has a market capitalization of $1.04 billion, a P/E ratio of 39.91 and a beta of 0.66. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. The stock has a 50 day moving average price of $26.13 and a two-hundred day moving average price of $25.87. TriMas Co. has a 12-month low of $22.45 and a 12-month high of $28.51.
TriMas (NASDAQ:TRS – Get Free Report) last announced its earnings results on Monday, November 4th. The industrial products company reported $0.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.14). TriMas had a return on equity of 9.21% and a net margin of 2.93%. The company had revenue of $229.36 million for the quarter, compared to the consensus estimate of $239.33 million. During the same period in the previous year, the company earned $0.57 EPS. The firm’s revenue for the quarter was down 2.5% compared to the same quarter last year. Equities analysts expect that TriMas Co. will post 1.74 earnings per share for the current year.
TriMas Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, November 12th. Investors of record on Tuesday, November 5th were given a $0.04 dividend. The ex-dividend date of this dividend was Tuesday, November 5th. This represents a $0.16 annualized dividend and a yield of 0.63%. TriMas’s dividend payout ratio (DPR) is currently 25.00%.
TriMas Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Further Reading
- Five stocks we like better than TriMas
- Best Stocks Under $10.00
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- 3 Healthcare Dividend Stocks to Buy
- Top-Performing Non-Leveraged ETFs This Year
- There Are Different Types of Stock To Invest In
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS – Free Report).
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.